GeneDx (WGS, Financial) is set to enhance its capabilities in genomic medicine by acquiring Fabric Genomics, a leader in AI-driven genomic interpretation. This strategic acquisition aims to bolster GeneDx’s position in decentralized genomic testing while integrating centralized intelligence.
Under the agreement, GeneDx will pay up to $33 million in cash upon the closing of the transaction. The total consideration may reach up to $51 million if specific milestones are successfully met. The company’s Board of Directors has already approved the acquisition unanimously, underscoring its strategic importance.
The transaction is projected to finalize in the second quarter of 2025, contingent upon meeting customary closing conditions. This development marks a significant step forward in GeneDx's strategic initiatives to expand its role in the rapidly evolving field of genomic medicine.
Wall Street Analysts Forecast
Based on the one-year price targets offered by 6 analysts, the average target price for GeneDx Holdings Corp (WGS, Financial) is $107.33 with a high estimate of $135.00 and a low estimate of $80.00. The average target implies an upside of 5.00% from the current price of $102.22. More detailed estimate data can be found on the GeneDx Holdings Corp (WGS) Forecast page.
Based on the consensus recommendation from 6 brokerage firms, GeneDx Holdings Corp's (WGS, Financial) average brokerage recommendation is currently 2.3, indicating "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
Based on GuruFocus estimates, the estimated GF Value for GeneDx Holdings Corp (WGS, Financial) in one year is $16.86, suggesting a downside of 83.51% from the current price of $102.22. GF Value is GuruFocus' estimate of the fair value that the stock should be traded at. It is calculated based on the historical multiples the stock has traded at previously, as well as past business growth and the future estimates of the business' performance. More detailed data can be found on the GeneDx Holdings Corp (WGS) Summary page.
